Tenax Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
TENX on Nasdaq
Location
101 Glen Lennox Drive, Suite 300, Chapel Hill, NC

Insiders trading volume in the past year

Tenax Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Thomas Giordano CEO, Director $10.1M +$20K +0.2% Nov 18, 2025
Stuart Rich Chief Medical Officer, Director $3.69M May 16, 2025
Michael H. Davidson Director $892K Jul 1, 2025
Proehl Gerald T Director $746K Jul 1, 2025
June Sherie Almenoff Director $593K +$14.9K +2.58% Nov 17, 2025
Declan Doogan Director $472K Jul 1, 2025
Robyn Hunter Director $459K Jul 1, 2025
Thomas Mcgauley Interim CFO $58.2K +$58.2K Nov 17, 2025
Anthony A. DiTonno CEO, Director Jul 6, 2021
Armistice Capital, Llc Director May 18, 2022
Dellora Investments LP no longer 10% owner Mar 5, 2025
Eliot M. Lurier Interim CFO Oct 29, 2021
James Mitchum Director Jun 10, 2021
Lawrence R. Hoffman Interim CFO Jan 11, 2024

Recent Insider Transactions by Companies or Individuals for Tenax Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.